News: Breakthrough £90,000 Alzheimer's drugs unlikely to benefit patients, report suggests
A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.
Status: 
Green Flag — General/neutral
Parent-approved: light & bright!
Talk it out: Who included others? How do we know?
Who included others? How do we know?
Family note: This post follows a democratic learning style — inviting student and parent voices, respectful debate, and shared decision‑making.
Leave a Reply